Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

12.5%

5 terminated/withdrawn out of 40 trials

Success Rate

79.2%

-7.3% vs industry average

Late-Stage Pipeline

2 trials in Phase 3/4

Results Transparency

1 of 19 completed trials have results

Key Signals

4 recruiting1 with results

Enrollment Performance

Analytics

N/A

24(61.5%)

Phase 2

8(20.5%)

Phase 1

4(10.3%)

Early Phase 1

1(2.6%)

Phase 3

1(2.6%)

Phase 4

1(2.6%)

39Total

N/A(24)

Phase 2(8)

Phase 1(4)

Early Phase 1(1)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (40)

Showing 20 of 40 trials

NCT07216872Not ApplicableRecruiting

Safety and Effectiveness of the BrainsWay Deep Transcranial Magnetic Stimulation (Deep TMS) for Treatment of Alcohol Use Disorder (AUD)

Role: lead

NCT06357832Not ApplicableCompleted

New Investigational Stimulation Protocol for Treatment of Major Depression Disorder (MDD)

Role: lead

NCT06095063Not ApplicableRecruiting

dTMS for Subjective Cognitive Decline

Role: collaborator

NCT03665831Not ApplicableRecruiting

Deep TMS for Comorbid Depression and Cognitive Impairment in Older Adults

Role: collaborator

NCT07116785Not ApplicableRecruiting

Accelerated Rotational Field Deep TMS for Treating OCD

Role: collaborator

NCT04083144Not ApplicableCompleted

Deep rTMS and Varenicline for Smoking Cessation

Role: collaborator

NCT05404360Not ApplicableUnknown

Evaluation of the Long Term Efficacy and Durability of the BrainsWay Deep TMS in OCD Subjects

Role: lead

NCT01106365Not ApplicableCompleted

Repetitive Deep Transcranial Magnetic Stimulation in Multiple Sclerosis

Role: collaborator

NCT02260765Not ApplicableWithdrawn

Post Marketing Study to Evaluate the Resource Utilization of Patients Suffering From Resistant Depression Treated With Deep TMS in Comparison to Treatment as Usual

Role: lead

NCT01566591Not ApplicableUnknown

Safety and Efficacy Study of Deep Transcranial Magnetic Stimulation in Bipolar Depression

Role: lead

NCT04679753Phase 4Completed

Brainsway DTMS for Treatment of MDD Using iTBS

Role: lead

NCT02126124Phase 3Completed

Evaluation of Deep Transcranial Magnetic Stimulation (DTMS) With the H-ADD Coil as an Aid to Smoking Cessation.

Role: lead

NCT00927173Not ApplicableCompleted

Evaluation of the Brainsway Deep Transcranial Magnetic Stimulation (TMS) H-Coil in the Treatment of Major Depression Disorder

Role: lead

NCT01361815Not ApplicableCompleted

Prospective Multicenter Trial to Explore the Tolerability and Safety of the H-Coil Deep TMS in Combination With Serotonin Selective Reuptake Inhibitor(SSRI)

Role: lead

NCT03012724Not ApplicableUnknown

Efficacy of H7-Coil DTMS Compared to H1-Coil DTMS in Subjects With Major Depression Disorder (MDD)

Role: lead

NCT02229903Not ApplicableCompleted

An Evaluation of the Safety and Efficacy of the dTMS Treatment for OCD

Role: lead

NCT01464515Phase 1Unknown

Efficiency of Deep Transcranial Magnetic Stimulation on Patients With Mild Cognitive Impairment

Role: lead

NCT01196910Phase 1Unknown

Deep Transcranial Magnetic Stimulation (DTMS) as a Treatment for Attention Deficit Hyperactivity Disorder (ADHD) in Adults

Role: lead

NCT01343732Not ApplicableUnknown

Tolerability, Safety and Efficacy of the HAC-Coil Deep Transcranial Magnetic Stimulation in Medication Resistance Obsessive Compulsive Disorder (OCD) Subjects

Role: lead

NCT04455646Unknown

Combining H1-Coil Deep Transcranial Magnetic Stimulation (dTMS) and App-guided CBT in Subjects With Major Depression Disorder (MDD)

Role: lead